- £1.05bn
- £1.13bn
- £472.60m
- 64
- 21
- 93
- 63
2019 October 31st | 2020 October 31st | 2021 October 31st | R2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 335 | 403 | 393 | 401 | 473 |
Cost of Revenue | |||||
Gross Profit | 117 | 128 | 119 | 111 | 150 |
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 304 | 356 | 343 | 352 | 427 |
Operating Profit | 31.3 | 46.3 | 50.4 | 49.4 | 45.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 26.7 | 43.3 | 48.8 | 47.9 | 44.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 23.1 | 34.7 | 41.5 | 44.4 | 37.7 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 21.9 | 34.7 | 41.5 | 47.4 | 5.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 21.9 | 34.7 | 41.5 | 47.4 | 5.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.083 | 0.123 | 0.148 | 0.158 | 0.221 |
Dividends per Share |